Tandem Labs: Bioanalytical CRO offers validation of proinflammatory, cytokine multiplex biomarker assays

In an industry first, bioanalytical CRO Tandem Labs has announced the availability of biomarker assays for human clinical studies using the Meso Scale Discovery V-PLEX biomarker platform, which have been already validated by Tandem in human serum.